SEC 13F Intelligence

Edgar Lomax Co/Va / AMGN

Edgar Lomax Co/Va’s Amgen Inc Position

Does Edgar Lomax Co/Va own Amgen Inc (AMGN)? Yes49.0K shares worth $17M (+1.23% of its 13F portfolio) as of Q1 2026, down from 98.0K shares the prior filed quarter.

Position Value
$17M
Q1 2026
Shares
49.0K
% of Portfolio
+1.23%
Quarters Held
22
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’21: $37MQ2 ’21: $35MQ3 ’21: $30MQ3 ’21Q4 ’21: $31MQ1 ’22: $52MQ2 ’22: $54MQ2 ’22Q3 ’22: $49MQ4 ’22: $57MQ1 ’23: $60MQ1 ’23Q2 ’23: $54MQ3 ’23: $63MQ4 ’23: $65MQ4 ’23Q1 ’24: $42MQ2 ’24: $46MQ3 ’24: $47MQ3 ’24Q4 ’24: $37MQ1 ’25: $41MQ2 ’25: $36MQ2 ’25Q3 ’25: $28MQ4 ’25: $32MQ1 ’26: $17MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202649.0K$17M+1.23%
Q4 202598.0K$32M+2.44%
Q3 2025100.3K$28M+2.22%
Q2 2025130.3K$36M+2.30%
Q1 2025132.4K$41M+2.58%
Q4 2024141.7K$37M+2.38%
Q3 2024144.5K$47M+2.84%
Q2 2024146.7K$46M+2.97%
Q1 2024148.6K$42M+2.61%
Q4 2023226.0K$65M+4.26%
Q3 2023235.4K$63M+4.31%
Q2 2023244.0K$54M+3.57%
Q1 2023247.4K$60M+3.85%
Q4 2022217.9K$57M+3.47%
Q3 2022219.1K$49M+3.41%
Q2 2022221.5K$54M+3.37%
Q1 2022215.5K$52M+3.06%
Q4 2021139.7K$31M+1.88%
Q3 2021140.9K$30M+1.92%
Q2 2021142.3K$35M+2.15%
Q1 2021149.2K$37M+2.31%
Q4 201881.8K$16M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Edgar Lomax Co/Va’s full portfolio or all institutional holders of AMGN.